Molecular Templates Stock Shares Owned By Insiders
| MTEM Stock | USD 0.40 0.06 17.65% |
Molecular Templates fundamentals help investors to digest information that contributes to Molecular Templates' financial success or failures. It also enables traders to predict the movement of Molecular Stock. The fundamental analysis module provides a way to measure Molecular Templates' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Molecular Templates stock.
Molecular | Shares Owned By Insiders |
Molecular Templates Company Shares Owned By Insiders Analysis
Molecular Templates' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Molecular Templates Shares Owned By Insiders | 3.96 % |
Most of Molecular Templates' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Molecular Templates is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Molecular Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Molecular Templates is extremely important. It helps to project a fair market value of Molecular Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Molecular Templates' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Molecular Templates' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Molecular Templates' interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 3.96% of Molecular Templates are shares owned by insiders. This is 73.91% lower than that of the Biotechnology sector and 72.07% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 60.75% higher than that of the company.
Molecular Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molecular Templates' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Molecular Templates could also be used in its relative valuation, which is a method of valuing Molecular Templates by comparing valuation metrics of similar companies.Molecular Templates is currently under evaluation in shares owned by insiders category among its peers.
Molecular Templates Current Valuation Drivers
We derive many important indicators used in calculating different scores of Molecular Templates from analyzing Molecular Templates' financial statements. These drivers represent accounts that assess Molecular Templates' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Molecular Templates' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 528.4M | 447.0M | 216.8M | 18.6M | 16.8M | 16.0M | |
| Enterprise Value | 457.6M | 448.9M | 236.8M | 37.0M | 17.5M | 16.6M |
Molecular Fundamentals
| Return On Equity | -9.29 | ||||
| Return On Asset | -0.38 | ||||
| Profit Margin | (0.61) % | ||||
| Operating Margin | (14.50) % | ||||
| Current Valuation | 940.57 K | ||||
| Shares Outstanding | 6.58 M | ||||
| Shares Owned By Insiders | 3.96 % | ||||
| Shares Owned By Institutions | 35.00 % | ||||
| Number Of Shares Shorted | 270.13 K | ||||
| Price To Earning | (0.24) X | ||||
| Price To Book | 0.31 X | ||||
| Price To Sales | 0.09 X | ||||
| Revenue | 57.31 M | ||||
| Gross Profit | (45.97 M) | ||||
| EBITDA | 1.43 M | ||||
| Net Income | (8.12 M) | ||||
| Cash And Equivalents | 104.42 M | ||||
| Cash Per Share | 1.85 X | ||||
| Total Debt | 12.23 M | ||||
| Debt To Equity | 1.79 % | ||||
| Current Ratio | 2.40 X | ||||
| Book Value Per Share | 1.08 X | ||||
| Cash Flow From Operations | (41.82 M) | ||||
| Short Ratio | 0.02 X | ||||
| Earnings Per Share | (3.05) X | ||||
| Target Price | 18.0 | ||||
| Number Of Employees | 62 | ||||
| Beta | 1.22 | ||||
| Market Capitalization | 2.21 M | ||||
| Total Asset | 35.38 M | ||||
| Retained Earnings | (452.89 M) | ||||
| Working Capital | (549 K) | ||||
| Current Asset | 54.36 M | ||||
| Current Liabilities | 7.75 M | ||||
| Net Asset | 35.38 M |
About Molecular Templates Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Molecular Templates's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molecular Templates using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molecular Templates based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Molecular Templates Piotroski F Score and Molecular Templates Altman Z Score analysis. To learn how to invest in Molecular Stock, please use our How to Invest in Molecular Templates guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Templates. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Templates listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (3.05) | Revenue Per Share 4.544 | Quarterly Revenue Growth (0.92) | Return On Assets (0.38) |
The market value of Molecular Templates is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Templates' value that differs from its market value or its book value, called intrinsic value, which is Molecular Templates' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Templates' market value can be influenced by many factors that don't directly affect Molecular Templates' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Templates' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Templates is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Templates' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.